Use of Tools for Early Detection of Cerebral Palsy

NCT ID: NCT06531330

Last Updated: 2024-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High risk of infant is defined as an infant who has a history of negative environmental and biological factors and these factors can cause neuromotor development problems. This group is a heterogeneous group that includes premature babies born under thirty-seven weeks, term babies with low birth weight (LBW), or babies with developmental delays for various reasons. These infants are also monitored for Cerebral Palsy (CP). CP is the most common physical disability in childhood, with an incidence of 2.1 per 1000 births.In a 2017 clinical review of early diagnosis tools, a group of international experts published best practice recommendations, calling for early diagnosis to be made as a result of timely use of the recommended tools. The diagnosis of CP is typically made by a physician between 12 and 24 months of age, but in some cases it is delayed until 42 months.Correct and early use of the key tools required for early diagnosis may allow much earlier detection of CP for infants younger than 5 months or older.Early detection and monitoring of infants in the community for CP is essential only with appropriate, valid and reliable tools in order to minimize possible sequelae through timely implementation of CP-specific interventions. According to international guidelines, babies with high risk of CP should be followed up. This follow-up should be done by an interdisciplinary team such as neonatologist, pediatrician, pediatric neurologist, physiotherapist, speech-language-swallowing therapist, and special education specialist. Pediatric physiotherapists are an important part of this team in terms of developmental follow-up and rehabilitation. Therefore, it is important that the awareness level of pediatric physiotherapists in this field in our country is sufficient, they are equipped with various trainings and reach the international level. In this way, families at risk of CP can provide early guidance for their children, ensure early diagnosis of CP, and initiate treatment.The aim of this study is to evaluate the use of early diagnostic evaluation tools in at-risk of infants between the ages of 0-2 at risk of CP in pediatric physiotherapy practice in Turkey.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prematures make up the majority of risky babies; perinatal asphyxia, hypoxic ischemic encephalopathy (HIE), periventricular leukomalacia (PVL), intraventricular hemorrhage (IVH), respiratory distress syndrome (RSD), bronchopulmonary dysplasia (BPD), hyperbilirubinemia, viral infections, fetal alcohol syndrome, muscle tone disorders, hydrocephalus and They may encounter risk factors such as microcephaly.It is important to detect early atypical neurodevelopmental findings that may occur in at-risk of infants at later ages and direct them to the necessary intervention programs.In this context, all healthcare professionals in the follow-up of at-risk babies should follow developmental and medical follow-up guidelines and use various neuromotor assessment methods. It is also stated in the guidelines of the American Academy of Pediatrics (APA) and the high-risk baby monitoring guide of the Turkish Neonatology Association that these babies should be monitored periodically by a team.The importance of monitoring all premature infants, especially very low birth weight (VLBW) babies \<1500g, at least twice in the first year of their lives, with age-appropriate neuromotor and developmental evaluations is emphasized. In this way, infants; By determining motor, sensory, cognitive and social developmental delays, developmental problems in later ages can be predicted. In addition, physiotherapy and rehabilitation or special education needs can be determined in terms of early intervention and motor development, and early referral to appropriate support programs can be provided.The 3 methods with the best predictable validity that can determine CP before the corrected 5-month period are; Neonatal MRI (86%-89% sensitivity), Prechtl's GMs Evaluation (98% sensitivity), HINE (90% sensitivity). Using the HINE test alone was also found to be reliable in determining the development of CP. In recent years, studies have shown that the diagnosis of high-risk CP can be detected at the 3rd month with predictive validity and reliability by evaluating the quality of Prechtl's GMs movements.Early physiotherapy and rehabilitation in CP includes approaches starting from the neonatal period and up to 24 months. The main aim is to provide normal functional movements and normal sensory input by using the rapid learning ability resulting from brain plasticity.Velde et al. In order to implement a new evidence-based clinical guideline for early diagnosis in Australia, a study aimed to determine the age at diagnosis, suitability for recommended tests, and acceptability of the early diagnosis clinic for parents and referrers, by following patients according to international guidelines, estimated CP diagnosis between 4-8 months. They showed. The follow-up clinic in this study was found to be highly acceptable to parents and referrers. During this follow-up period, pediatricians had the highest referral rates (39%), followed by auxiliary healthcare professionals (31%), primary caregivers (14%) and other healthcare professionals (16%).In a study conducted among American pediatricians, it was stated that there was uncertainty about how to diagnose and refer babies with motor delays, and variability in knowledge and practices regarding the identification of motor delays in these babies. A study conducted with clinicians (pediatricians, physiotherapists and occupational therapists) in New Zealand investigated current clinical practices regarding awareness and use of diagnostic tools for the detection of CP. Despite high awareness of the risk of CP in New Zealand, current use of international best practice tools in the clinic has been observed to be low. Clinicians who do not make diagnoses within their professional roles also reported that the assessment tools were rarely used, with 74% never using GMs or HINE and 54% in assessing children at risk for CP. Barriers to use have been cited as lack of time or funding, lack of clear guidelines, and inadequate management support. In a study conducted with pediatric physiotherapists in Spain, the average age at which CP was suspected was 12.6 months. To evaluate and diagnose the risk of CP, most physiotherapists; stated that they used the child's clinical history (88.1%), AIMS (41.3%) and Vojta Assessment Procedure (32.1%). In Spain, physiotherapists were found to rarely use GMs (25.7%) and HINE (28.4%). These results showed that pediatric physiotherapists in Spain rely on clinical history and older tools to identify children with CP.In this study, it was aimed to determine the awareness levels about the importance of the use of these tools in terms of early diagnosis and intervention in CP in Turkey, the frequency of use and the reasons for the obstacles if they cannot be used. In this context, the awareness levels of physiotherapists in Turkey will be determined through a digital survey administered digitally to pediatric physiotherapists in Spain and translated into Turkish after obtaining the necessary permissions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Early Developmental Impairment Infant Development

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Pediatric physiotherapists working in Turkey

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Physiotherapists who have been working in the field of pediatric physiotherapy for at least 3 years

Exclusion Criteria

* Physiotherapists with any psychiatric diagnosis
Minimum Eligible Age

25 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gazi University

OTHER

Sponsor Role collaborator

Karadeniz Technical University

OTHER

Sponsor Role collaborator

Mustafa Kemal University

OTHER

Sponsor Role collaborator

Kahramanmaras Sutcu Imam University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hatice Adiguzel

Asistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hatice Adiguzel, PhD PT

Role: PRINCIPAL_INVESTIGATOR

Kahramanmaras Sutvu Imam University

Bulent Elbasan, Proffessor

Role: STUDY_DIRECTOR

Gazi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hatice

Kahramanmaraş, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KahramanmarasSIU2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.